Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 52

Sort by

Sort Order Select

Journal Articles

Outcomes of BCR::ABL1 -like B-Lineage Acute Lymphoblastic Leukemia in the Era of Novel Therapies

Blood (2024) 144 (Supplement 1): 5918.

https://doi.org/10.1182/blood-2024-208069

Published: 2024

Journal Articles

Clinical and Molecular Characterization of TP53-Mutant Acute Lymphoblastic Leukemia

Blood (2024) 144 (Supplement 1): 1425.

https://doi.org/10.1182/blood-2024-212213

Published: 2024

Journal Articles

Malignant progression of preleukemic disorders

Trent Hall, Sandeep Gurbuxani, John D. Crispino

Blood (2024) 143 (22): 2245–2255.

https://doi.org/10.1182/blood.2023020817

Published: 2024

Journal Articles

SETBP1 sets the stage

Sandeep Gurbuxani

Blood (2024) 143 (14): 1323–1324.

https://doi.org/10.1182/blood.2023023757

Published: 2024

Journal Articles

Early Peripheral Blood Minimal Residual Disease Status By NGS in Patients with Newly Diagnosed Multiple Myeloma (MM) on a Phase 2 Trial Receiving Elotuzumab, Carfilzomib, Lenalidomide, and Dexamethasone (Elo-KRd)

Ben A Derman, Tadeusz Kubicki, Heidi Simmons, Aimaz Afrough, Jeffrey A. Zonder, David L. Grinblatt, Larry D. Anderson, Jr., Andrew Kin, Sunil Narula, Shayan Rayani, Sandeep Gurbuxani, Theodore Karrison, Ken Jiang, Ajay Major, Jennifer H Cooperrider, Allison P. Jacob, Andrzej J Jakubowiak

Blood (2023) 142 (Supplement 1): 1982.

https://doi.org/10.1182/blood-2023-182410

Published: 2023

Journal Articles

Socioeconomic Determinants and the Biology and Outcomes of Acute Lymphoblastic Leukemia in Adults

Blood (2023) 142 (Supplement 1): 1468.

https://doi.org/10.1182/blood-2023-174963

Published: 2023

Journal Articles

Targeting BCMA in Plasmablastic Lymphoma: Two Cases of Therapeutic Response to Teclistamab

Joseph Cannova, Adam S. Duvall, Girish Venkataraman, Geoffrey D. Wool, Sandeep Gurbuxani, Peter A. Riedell

Blood (2023) 142 (Supplement 1): 6282.

https://doi.org/10.1182/blood-2023-190814

Published: 2023

Journal Articles

Analysis of CD58 As a Predictive Marker of Morphologic Response to Inotuzumab Ozogamicin in Patients with B-Cell Acute Lymphoblastic Leukemia

Rafael Madero-Marroquin, Ryan Hunter, Caner Saygin, Hannah Johnston, Hamed Rahmani Youshanlouei, Clinton Osei, Wendy Stock, Sandeep Gurbuxani, Anand Ashwin Patel

Blood (2023) 142 (Supplement 1): 6071.

https://doi.org/10.1182/blood-2023-180883

Published: 2023

Journal Articles

EBV-positive inflammatory FDC/FRC tumor: no longer pseudo or sarcoma!

Ryan W. Hunter, Sandeep Gurbuxani

Blood (2023) 141 (8): 961.

https://doi.org/10.1182/blood.2022018463

Published: 2023

Journal Articles

IL-13/IL-4 signaling contributes to fibrotic progression of the myeloproliferative neoplasms

Johanna Melo-Cardenas, Lavanya Bezavada, Jeremy Chase Crawford, Sandeep Gurbuxani, Anitria Cotton, Guolian Kang, Jeffrey Gossett, Christian Marinaccio, Rona Weinberg, Ronald Hoffman, Anna Rita Migliaccio, Yan Zheng, Marta Derecka, Ciro R. Rinaldi, John D. Crispino

Blood (2022) 140 (26): 2805–2817.

https://doi.org/10.1182/blood.2022017326

Published: 2022

Includes: Supplemental data

Journal Articles

Predictors of Adverse Clinical Outcome in Diffuse Large B-Cell Lymphoma Richter Transformation of CLL/SLL: A Consortium of Richter Transformation Investigators (CORTI) Multicenter Study across 8 US, UK, and Australian Academic Centers

Blood (2022) 140 (Supplement 1): 2053–2055.

https://doi.org/10.1182/blood-2022-155950

Published: 2022

Journal Articles

Molecular Characterization of Adult Acute Lymphoblastic Leukemia Identifies a Subgroup with Myeloid Mutations and Pre-Existing Clonal Hematopoiesis

Blood (2022) 140 (Supplement 1): 1050–1052.

https://doi.org/10.1182/blood-2022-167977

Published: 2022

Journal Articles

CUX1 Deficiency Potentiates RAS Signaling to Drive Malignancy

Ningfei An, Molly K Imgruet, Saira Khan, Lia Jueng, Sandeep Gurbuxani, Megan E. McNerney

Blood (2021) 138 (Supplement 1): 1159.

https://doi.org/10.1182/blood-2021-148694

Published: 2021

Journal Articles

IL13 Contributes to Fibrotic Progression of the Myeloproliferative Neoplasms

Johanna Melo-Cardenas, Lavanya Bezavada, Jeremy Chase Crawford, Sandeep Gurbuxani, Anitria Cotton, Christian Marinaccio, John D. Crispino

Blood (2021) 138 (Supplement 1): 60.

https://doi.org/10.1182/blood-2021-151492

Published: 2021

Journal Articles

Type 1 Calreticulin Mutations Differentially Activate the IRE1α-XBP1 Pathway of the Unfolded Protein Response to Drive Myeloproliferative Neoplasms

Blood (2021) 138 (Supplement 1): 628.

https://doi.org/10.1182/blood-2021-147859

Published: 2021

Journal Articles

bcr3 PML-RARA : short fusion, small blasts!

Moe R. Takeda, Sandeep Gurbuxani

Blood (2021) 137 (19): 2708.

https://doi.org/10.1182/blood.2021010965

Published: 2021

Journal Articles

Carfilzomib, lenalidomide, and dexamethasone plus transplant in newly diagnosed multiple myeloma

Blood (2020) 136 (22): 2513–2523.

https://doi.org/10.1182/blood.2020007522

Published: 2020

Includes: Supplemental data

Journal Articles

Expanding Use of a Modified Pediatric Intensive Regimen for Acute Lymphoblastic Leukemia (ALL) into an Older Adult Population: Feasibility and Efficacy Results

Anand Ashwin Patel, MD, Joseph Heng, MD, Emily Dworkin, PharmD, Sarah Monick, MD, Benjamin A Derman, MD, Sandeep Gurbuxani, MBBS, PhD, Satyajit Kosuri, MD, Hongtao Liu, MD PhD, Michael Thirman, MD, Lucy A. Godley, Olatoyosi Odenike, MD, Richard A. Larson, MD, Wendy Stock, MD

Blood (2020) 136 (Supplement 1): 41–42.

https://doi.org/10.1182/blood-2020-138967

Published: 2020

Journal Articles

Loss of LKB1/ STK11 Facilitates Leukemic Progression of the Myeloproliferative Neoplasms

Christian Marinaccio, MSc, Praveen K Suraneni, PhD, Hamza Celik, PhD, Andrew Volk, PhD, Jeremy Q. Wen, MD PhD, Te Ling, PhD, Terra Lasho, PhD, Richard P. Koche, PhD, Christopher Famulare, MS, Brady L. Stein, MD, Sandeep Gurbuxani, MBBS, PhD, Ronald Hoffman, MD, Naseema Gangat, MBBS, Navdeep Chandel, Ross L. Levine, MD, Raajit K. Rampal, MD PhD, Grant Challen, Ayalew Tefferi, MD, John D. Crispino, PhD

Blood (2020) 136 (Supplement 1): 1.

https://doi.org/10.1182/blood-2020-140557

Published: 2020

Journal Articles

CXCL4’s “Gliful” subversion of BM in MPN

Sandeep Gurbuxani

Blood (2020) 136 (18): 1999–2000.

https://doi.org/10.1182/blood.2020007943

Published: 2020

NARROW

Outcomes of BCR::ABL1 -like B-Lineage Acute Lymphoblastic Leukemia in the Era of Novel Therapies

Clinical and Molecular Characterization of TP53-Mutant Acute Lymphoblastic Leukemia

Malignant progression of preleukemic disorders

SETBP1 sets the stage

Early Peripheral Blood Minimal Residual Disease Status By NGS in Patients with Newly Diagnosed Multiple Myeloma (MM) on a Phase 2 Trial Receiving Elotuzumab, Carfilzomib, Lenalidomide, and Dexamethasone (Elo-KRd)

Socioeconomic Determinants and the Biology and Outcomes of Acute Lymphoblastic Leukemia in Adults

Targeting BCMA in Plasmablastic Lymphoma: Two Cases of Therapeutic Response to Teclistamab

Analysis of CD58 As a Predictive Marker of Morphologic Response to Inotuzumab Ozogamicin in Patients with B-Cell Acute Lymphoblastic Leukemia

EBV-positive inflammatory FDC/FRC tumor: no longer pseudo or sarcoma!

IL-13/IL-4 signaling contributes to fibrotic progression of the myeloproliferative neoplasms

Predictors of Adverse Clinical Outcome in Diffuse Large B-Cell Lymphoma Richter Transformation of CLL/SLL: A Consortium of Richter Transformation Investigators (CORTI) Multicenter Study across 8 US, UK, and Australian Academic Centers

Molecular Characterization of Adult Acute Lymphoblastic Leukemia Identifies a Subgroup with Myeloid Mutations and Pre-Existing Clonal Hematopoiesis

CUX1 Deficiency Potentiates RAS Signaling to Drive Malignancy

IL13 Contributes to Fibrotic Progression of the Myeloproliferative Neoplasms

Type 1 Calreticulin Mutations Differentially Activate the IRE1α-XBP1 Pathway of the Unfolded Protein Response to Drive Myeloproliferative Neoplasms

bcr3 PML-RARA : short fusion, small blasts!

Carfilzomib, lenalidomide, and dexamethasone plus transplant in newly diagnosed multiple myeloma

Expanding Use of a Modified Pediatric Intensive Regimen for Acute Lymphoblastic Leukemia (ALL) into an Older Adult Population: Feasibility and Efficacy Results

Loss of LKB1/ STK11 Facilitates Leukemic Progression of the Myeloproliferative Neoplasms

CXCL4’s “Gliful” subversion of BM in MPN

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only